We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+0.55%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$48B
AUM Growth
-$1.59B
(-3.2%)
Cap. Flow
-$1.46B
Cap. Flow
% of AUM
-3.05%
Top 10 Holdings %
Top 10 Hldgs %
24.06%
Holding
1,904
New
84
Increased
534
Reduced
502
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$60.6M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$50.8M |
| 3 |
Mastercard
MA
|
+$43.1M |
| 4 |
Analog Devices
ADI
|
+$40.3M |
| 5 |
Broadcom
AVGO
|
+$40.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$92.3M |
| 2 |
NVIDIA
NVDA
|
+$92.1M |
| 3 |
Eli Lilly
LLY
|
+$80.8M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$74.2M |
| 5 |
Microsoft
MSFT
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.14% |
| 2 | Financials | 15.08% |
| 3 | Healthcare | 14.69% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Communication Services | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
US Physical Therapy
USPH
$1.2B
| $15.7M | 0.03% |
142,146
+48,053
| +51% | +$5.48M |
|
352
Stanley Black & Decker
SWK
$14.6B
| $15.6M | 0.03% |
89,192
+3,043
| +4% | +$593K |
|
|
DISCK
353
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $15.6M | 0.03% |
644,181
-134,834
| -17% | -$3.6M |
|
354
Kimberly-Clark
KMB
$37.5B
| $15.4M | 0.03% |
116,552
-12,780
| -10% | -$1.74M |
|
355
Western Union
WU
$2.58B
| $15.4M | 0.03% |
762,669
-126,843
| -14% | -$2.8M |
|
356
American Electric Power
AEP
$72.4B
| $15.3M | 0.03% |
188,579
-6,095
| -3% | -$532K |
|
357
MSCI
MSCI
$42.1B
| $15.2M | 0.03% |
24,972
+15,625
| +167% | +$9.55M |
|
|
SILK
358
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $15M | 0.03% |
272,532
+18,055
| +7% | +$945K |
|
|
SRCL
359
DELISTED
Stericycle Inc
SRCL
| $14.8M | 0.03% |
218,098
+12,373
| +6% | +$855K |
|
360
Consolidated Edison
ED
$41.3B
| $14.7M | 0.03% |
202,982
-5,135
| -2% | -$383K |
|
361
3M
MMM
$94.1B
| $14.7M | 0.03% |
100,385
-7,908
| -7% | -$1.28M |
|
|
SBNY
362
DELISTED
Signature Bank
SBNY
| $14.7M | 0.03% |
54,009
+6,625
| +14% | +$1.66M |
|
363
Evergy
EVRG
$19.7B
| $14.6M | 0.03% |
233,979
-8,935
| -4% | -$586K |
|
364
Camden Property Trust
CPT
$11.4B
| $14.5M | 0.03% |
98,533
+7,130
| +8% | +$1.05M |
|
365
Lam Research
LRCX
$337B
| $14.3M | 0.03% |
251,600
-43,120
| -15% | -$2.62M |
|
366
Lamb Weston
LW
$7.51B
| $14.2M | 0.03% |
231,840
+130,832
| +130% | +$8.86M |
|
367
Quest Diagnostics
DGX
$26B
| $14.2M | 0.03% |
97,520
-20,280
| -17% | -$2.97M |
|
368
HF Sinclair
DINO
$16.1B
| $14.2M | 0.03% |
427,545
-61,905
| -13% | -$1.88M |
|
369
Vistra
VST
$50.1B
| $14.1M | 0.03% |
826,073
-256,030
| -24% | -$4.73M |
|
370
Mohawk Industries
MHK
$7.14B
| $14.1M | 0.03% |
79,421
-2,488
| -3% | -$482K |
|
371
Domino's
DPZ
$11.6B
| $13.8M | 0.03% |
28,939
-23,246
| -45% | -$11.8M |
|
|
MRTX
372
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $13.7M | 0.03% |
77,707
+28,835
| +59% | +$4.64M |
|
373
State Street Industrial Select Sector SPDR ETF
XLI
$33.3B
| $13.7M | 0.03% |
139,762
+132,453
| +1,812% | +$13.6M |
|
374
Jazz Pharmaceuticals
JAZZ
$16.1B
| $13.6M | 0.03% |
104,720
-28,375
| -21% | -$4.29M |
|
375
Roblox
RBLX
$35.4B
| $13.6M | 0.03% |
180,314
+26,397
| +17% | +$2.17M |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Ensign Peak Advisors held 1,904 positions worth $48B, down 3.2% from $49.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ensign Peak Advisors withdrew a net $1.46B in Q3 2021, closing 55 positions and reducing 502 holdings. Its most notable exit was Root, an estimated $29.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ensign Peak Advisors opened a new position in State Street SPDR S&P Biotech ETF worth $37.7M.
- Ensign Peak Advisors's largest Q3 2021 buy was State Street SPDR S&P Biotech ETF: 300,000 shares worth $37.7M.
- Ensign Peak Advisors added most to AbbVie in Q3 2021, an estimated $60.6M increase.
- Ensign Peak Advisors's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $92.3M.
- Ensign Peak Advisors fully exited Root in Q3 2021, selling an estimated $29.6M.
- Ensign Peak Advisors's ten largest holdings make up 24% of its $48B portfolio in Q3 2021.
- Ensign Peak Advisors opened 84 new positions and closed 55 in Q3 2021.
- Ensign Peak Advisors's portfolio value fell 3.2% quarter-over-quarter to $48B.
Based on Ensign Peak Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.